about
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trialsB Cells and Functional Antibody Responses to Combat InfluenzaInduction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activityOriginal Antigenic Sin Response to RNA Viruses and Antiviral ImmunityA caprine herpesvirus 1 vaccine adjuvanted with MF59™ protects against vaginal infection and interferes with the establishment of latency in goatsEstimation of the health impact and cost-effectiveness of influenza vaccination with enhanced effectiveness in CanadaObesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination.Clinical vaccine development for H5N1 influenza.An empirical approach towards the efficient and optimal production of influenza-neutralizing ovine polyclonal antibodies demonstrates that the novel adjuvant CoVaccine HT™ is functionally superior to Freund's adjuvantGLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza.Heterologous prime-boost vaccination with MF59-adjuvanted H5 vaccines promotes antibody affinity maturation towards the hemagglutinin HA1 domain and broad H5N1 cross-clade neutralizationImmunological characterization of monoclonal antibodies used in rapid influenza diagnostic test for detection of the 2009 pandemic influenza A(H1N1)pdm09 infection.Oral priming with replicating adenovirus serotype 4 followed by subunit H5N1 vaccine boost promotes antibody affinity maturation and expands H5N1 cross-clade neutralization.Non-clinical safety and biodistribution of AS03-adjuvanted inactivated pandemic influenza vaccines.Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strainsBCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study.Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.Induction of Broad-Based Immunity and Protective Efficacy by Self-amplifying mRNA Vaccines Encoding Influenza Virus HemagglutininLongitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain.Determination of antigenicity-altering patches on the major surface protein of human influenza A/H3N2 virusesMF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines.Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccineInfection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.Seasonal H1N1 influenza virus infection induces cross-protective pandemic H1N1 virus immunity through a CD8-independent, B cell-dependent mechanism.Comparison of the long-term immunogenicity of two pandemic influenza A/H1N1 2009 vaccines, the MF59-adjuvanted and unadjuvanted vaccines, in adultsPandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.Long-term vaccine-induced heterologous protection against H5N1 influenza viruses in the ferret model.Vaccination against influenza: role and limitations in pandemic intervention plans.Adjuvant solution for pandemic influenza vaccine productionEmergence of a norovirus GII.4 strain correlates with changes in evolving blockade epitopes.Long-term immunogenicity of the pandemic influenza A/H1N1 2009 vaccine among health care workers: influence of prior seasonal influenza vaccination.Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus.Understanding immunosenescence to improve responses to vaccinesEx vivo analysis of human memory B lymphocytes specific for A and B influenza hemagglutinin by polychromatic flow-cytometry.New Orf virus (Parapoxvirus) recombinant expressing H5 hemagglutinin protects mice against H5N1 and H1N1 influenza A virus.Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunityActive Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated ImmunityOverview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.Age-Associated Failure To Adjust Type I IFN Receptor Signaling Thresholds after T Cell ActivationHigh-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine
P2860
Q21131308-D7DB14B0-C26E-4E95-81B8-DC9974C6D49DQ26801639-C9FE8923-0CD0-4AF2-AA1B-9BDBBA6550CEQ27309214-284EA8F0-3776-45FD-BD8F-06F5B57764C3Q28066918-E51BBC5C-8987-4E62-A3DA-C4B0494773B1Q28730610-681700BD-1671-473F-9BC5-E407AA91078CQ28742771-D34170E4-FF8C-429B-B36A-8CA2217F6FF3Q30151873-EB781AC6-E36D-4BF3-8580-41664165D00CQ30222083-8FF6C64B-32E3-49FE-AEEF-37F1C75765D3Q30352423-288BB426-D806-4960-BCDA-0712DF2274A1Q30359243-F5AD21D1-98C1-4B7D-9E94-22CADA366340Q30361644-13664DDE-11AB-47F2-8792-64F49B716B51Q30371141-257B7B87-B833-4DD7-BD34-AB72A1F98B90Q30371162-AB485656-1696-45AD-A177-27340D56642AQ30372260-7DD3F270-CC15-4709-956A-60F92D46130AQ30374968-428D5CAD-34D0-4106-97FA-B14744ED3526Q30375629-80480F77-C011-4B93-91F6-9A270CFBD89DQ30376724-3E2F33D0-ACC9-4326-B01E-04E31791D95BQ30380290-65581B99-4B68-4CB7-B419-7AF1E5D60146Q30381895-664DC4C8-714D-4E3B-A3C8-C7BDE5C012EFQ30394447-554A7C26-D08F-4158-A0B8-CBADC31B3AC7Q30403361-8A400D17-36B4-47C4-9D65-DAF7CFAE4D4CQ30406344-114362B4-B8B2-441E-AED1-7BB833AA7DA4Q30407851-5D4479BE-ADB1-417E-8E18-1F9471AF9487Q30410126-AE5FE2FD-17D3-4A06-8955-0D632C02A8DDQ30413670-152B516B-16DF-4E96-8B97-942382CFEA9BQ30417080-16F44CCC-AE32-4C26-BB0F-7A405F165745Q30420397-794E102F-734A-4441-9E46-7CA93D8EC11FQ30421562-0FF1DAF1-0F19-473C-B1F8-A2286E03FC14Q30422038-3EB8739C-359F-416E-BD94-B7E668DBDBFBQ30425145-77572DE5-AB1A-444F-AA1E-6CD67D65202CQ30426547-EF5E249D-B693-446A-9BBD-2DBF7FF79FECQ30427778-AA6AEA7B-908A-42CA-BFBE-839A40CBBC4CQ34281329-7C496871-8EC1-43ED-AB9A-24CBCDEAEE86Q34970276-A0AAF21F-5C78-4C09-A5C0-7869E4C0D5E8Q35078213-FE0E6BD5-F582-40EE-961D-D7803107D3B8Q35128920-FC43F0B7-65A2-424F-847F-4BE7D9681EE8Q35762600-E4E08609-8148-4CC0-A551-D21DEA55A8AAQ35826733-A4E3C5C8-3A70-4898-99F7-8E12A18DA45FQ35864559-EC40D8D5-5165-4104-9E41-524D1E124376Q36078779-8C04EEB4-0E13-4D18-BB12-D7BC19B5BC44
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Influenza vaccine immunology.
@ast
Influenza vaccine immunology.
@en
type
label
Influenza vaccine immunology.
@ast
Influenza vaccine immunology.
@en
prefLabel
Influenza vaccine immunology.
@ast
Influenza vaccine immunology.
@en
P2093
P2860
P1476
Influenza vaccine immunology.
@en
P2093
Flora Castellino
Giuseppe Del Giudice
Grazia Galli
Hana Golding
Philip R Dormitzer
Surender Khurana
P2860
P304
P356
10.1111/J.1600-065X.2010.00974.X
P577
2011-01-01T00:00:00Z